Open Payments

Hospital For Special Surgery

Type
Teaching hospital
Where
New York, NY
Medicare CCN
330270
Received
$6,238,951 in 389 records, 2020 ($3,891,735 general, $2,347,215 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment204$3,891,735
2020Research payment185$2,347,215

By company

CompanyRecordsAmountYears
Lima USA, Inc.5$1,585,6652020
EXACTECH, INC.14$1,083,4542020
Smith+Nephew, Inc.85$916,2312020
GE HEALTHCARE5$693,1272020
PFIZER INC.1$250,0002020
Zimmer Biomet Holdings, Inc.29$232,0052020
Stryker Corporation44$208,7022020
Limacorporate S.p.A.3$145,2812020
NuVasive, Inc.1$125,0002020
Regeneron Pharmaceuticals, Inc.6$123,1082020
Synthes GmbH6$110,0002020
Radius Health, Inc.1$90,1132020
Medical Device Business Services, Inc.27$71,9532020
Alexion Pharmaceuticals, Inc.10$50,0752020
UCB SA7$42,1652020
Orion Corporation7$40,3542020
Teva Pharmaceuticals USA, Inc.14$39,3342020
AstraZeneca UK Limited3$37,3902020
Kadmon Corporation LLC2$31,0982020
Medtronic USA, Inc.4$30,4582020
BioMarin Pharmaceutical Inc.1$29,6472020
ORTHOSENSOR INC.1$28,5792020
CSL Behring15$23,3952020
Orthofix Medical, Inc.4$20,2592020
OMNIlife science, Inc1$20,1822020
Cumberland Pharmaceuticals, Inc.1$17,2522020
Globus Medical, Inc.1$15,4172020
Ortho Development Corporation15$15,0152020
Takeda Pharmaceuticals U.S.A., Inc.5$14,2042020
Wright Medical Technology, Inc.1$14,0272020
MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC.1$13,9002020
AstraZeneca Pharmaceuticals LP1$13,9002020
Amgen Inc.4$12,6752020
Aesculap, Inc.1$12,3142020
BioFire Diagnostics, LLC8$10,6292020
ACUMED LLC12$10,5682020
TREACE MEDICAL CONCEPTS, INC.2$9,9622020
Boehringer Ingelheim Pharmaceuticals, Inc.2$9,5412020
E.R. Squibb & Sons, L.L.C.1$8,9602020
Engage Uni, LLC1$8,8402020
Aesculap Implant Systems, LLC2$6,2142020
KCI USA, Inc.4$4,8572020
Abbott Laboratories12$4,6852020
Surgalign Spine Technologies, Inc.1$3,8932020
DJO, LLC1$1,6502020
Boehringer Ingelheim Pharma GmbH & Co.KG13$8752020
UOC USA INC2$8252020
Novartis Pharmaceuticals Corporation1$8152020
Linvatec Corporation1$3392020

By nature of payment

NatureRecordsAmount
Research payment185$2,347,215
Space rental or facility fees (teaching hospital only)55$1,773,925
Royalty or License18$999,699
Grant75$829,514
Consulting Fee5$146,106
Gift15$86,087
Compensation for services other than consulting, including serving as faculty or as a speaker at a v33$47,845
Education2$8,199
Charitable Contribution1$357

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Globus Medical, Inc.$15,417GrantCash or cash equivalent Device, Spine2020
2020-12-31Stryker Corporation$14,662GiftIn-kind items and servicesCROSSFIRE 2 INTEGRATED RESECTION & ENERGY SYSTEM Device, ARTHROSCOPY2020
2020-12-31Stryker Corporation$14,662GiftIn-kind items and servicesCROSSFIRE 2 INTEGRATED RESECTION & ENERGY SYSTEM Device, ARTHROSCOPY2020
2020-12-31Stryker Corporation$13,779GiftIn-kind items and servicesCROSSFLOW PUMP Device, ARTHROSCOPY2020
2020-12-31Stryker Corporation$13,779GiftIn-kind items and servicesCROSSFLOW PUMP Device, ARTHROSCOPY2020
2020-12-31AstraZeneca UK Limited$7,597Research paymentIn-kind items and servicesThe purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre R2020
2020-12-31Stryker Corporation$7,576GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31Stryker Corporation$1,520GiftIn-kind items and servicesCROSSFIRE FOOTSWITCH Device, SPORTS MEDICINE2020
2020-12-31Stryker Corporation$1,520GiftIn-kind items and servicesCROSSFIRE FOOTSWITCH Device, SPORTS MEDICINE2020
2020-12-31Abbott Laboratories$315Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-12-31Stryker Corporation$0GiftCash or cash equivalentNONE Device, NONE2020
2020-12-29PFIZER INC.$250,000GrantCash or cash equivalent2020
2020-12-23GE HEALTHCARE$600,071Research paymentCash or cash equivalent Device, MAGNETIC RESONANCEDEVELOPMENT OF TECHNOLOGY TO EXTEND SCOPE OF MRI2020
2020-12-22Medical Device Business Services, Inc.$5,000GrantCash or cash equivalent2020
2020-12-22Stryker Corporation$1,500Research paymentCash or cash equivalentTRIDENT Device, HIPSMETAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANC2020
2020-12-17Alexion Pharmaceuticals, Inc.$6,910Research paymentCash or cash equivalentSafety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis2020
2020-12-17Smith+Nephew, Inc.$606Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-12-16Stryker Corporation$30,895Research paymentCash or cash equivalentMAKO Device, KNEES, HIPSMULTICENTER STUDY FOR ROBOTIC-ARM ASSISTED THA 4.0 SYSTEM WITH INTEGRATION OF PELVIC TILT AND ROM ASSESSMENTS: IMPLANT P2020
2020-12-15Orthofix Medical, Inc.$4,304Research paymentCash or cash equivalentM6-C Artificial Cervical Disc Device, Prosthesis, Intervertebral DiscM6-C IDE2020
2020-12-15Ortho Development Corporation$1,907Royalty or LicenseCash or cash equivalentSpinal Rod Device, ORTHOPEDIC DEVICE2020
2020-12-14EXACTECH, INC.$5,422Space rental or facility fees (teaching hospital only)Cash or cash equivalentVANTAGE Device, ORTHOPAEDIC2020
2020-12-14UCB SA$22Research paymentIn-kind items and servicesA RANDOMIZED, OPEN LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF ROZANOLIXIZU2020
2020-12-11Aesculap Implant Systems, LLC$3,774GiftCash or cash equivalent2020
2020-12-11Aesculap Implant Systems, LLC$2,440GiftCash or cash equivalent2020
2020-12-11KCI USA, Inc.$1,750Research paymentCash or cash equivalentPREVENA Device, NON-COVEREDClosed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty2020
2020-12-10Aesculap, Inc.$12,314GiftCash or cash equivalent2020
2020-12-10Orthofix Medical, Inc.$2,869Research paymentCash or cash equivalentM6-C Artificial Cervical Disc Device, Prosthesis, Intervertebral DiscM6-C IDE2020
2020-12-10Abbott Laboratories$746Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-12-09Stryker Corporation$19,067Research paymentCash or cash equivalentTRIDENT Device, HIPSMETAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANC2020
2020-12-09ACUMED LLC$2,275Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$2,275Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$1,743Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09Stryker Corporation$1,475Research paymentCash or cash equivalentRESTORATION Device, HIPSRESTORATION; ANATOMIC DUAL MOBILITY (ADM) X3; ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE; I2020
2020-12-09ACUMED LLC$955Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$955Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$925Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$360Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$250Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$250Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$200Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$200Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-09ACUMED LLC$180Space rental or facility fees (teaching hospital only)Cash or cash equivalent Device, Foot & Ankle2020
2020-12-08Alexion Pharmaceuticals, Inc.$6,680Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-12-08Smith+Nephew, Inc.$4,914Space rental or facility fees (teaching hospital only)Cash or cash equivalentAMBIENT HIPVAC Device, Sports Med Hip2020
2020-12-08Smith+Nephew, Inc.$4,186Space rental or facility fees (teaching hospital only)Cash or cash equivalentLENS Device, Sports Med Visualization2020
2020-12-08Smith+Nephew, Inc.$4,186Space rental or facility fees (teaching hospital only)Cash or cash equivalentJOURNEY II Device, Recon Knees2020
2020-12-08Smith+Nephew, Inc.$4,185Space rental or facility fees (teaching hospital only)Cash or cash equivalentWEREWOLF Device, Sports Med Resection2020
2020-12-08Smith+Nephew, Inc.$3,678Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLENS Device, Sports Med Visualization2020
2020-12-08Smith+Nephew, Inc.$3,623Space rental or facility fees (teaching hospital only)Cash or cash equivalentQ-FIX Shoulder Device, Sports Med Shoulder2020
2020-12-08Smith+Nephew, Inc.$3,508Space rental or facility fees (teaching hospital only)Cash or cash equivalentACUFEX Device, Sports Med Knee2020
2020-12-08Smith+Nephew, Inc.$2,122Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJOURNEY II Device, Recon Knees2020
2020-12-08Smith+Nephew, Inc.$799Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentAMBIENT HIPVAC Device, Sports Med Hip2020
2020-12-08Smith+Nephew, Inc.$799Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentQ-FIX Shoulder Device, Sports Med Shoulder2020
2020-12-08Smith+Nephew, Inc.$705Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentACUFEX Device, Sports Med Knee2020
2020-12-08Smith+Nephew, Inc.$525Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentWEREWOLF Device, Sports Med Resection2020
2020-12-03Smith+Nephew, Inc.$13,096Research paymentIn-kind items and servicesOXINIUM Hip Device, Recon Hips2020
2020-12-03EXACTECH, INC.$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentNOVATION HIP Device, ORTHOPAEDIC2020
2020-12-02Stryker Corporation$12,710Research paymentCash or cash equivalentT2 Device, TRAUMA & EXTREMETIESMAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM2020
2020-12-02Smith+Nephew, Inc.$1,653Research paymentCash or cash equivalentBIRMINGHAM HIP Device, Recon HipsA Post-Approval Study of the Birmingham Hip Resurfacing (BHR) Radiological System Review2020
2020-12-01Boehringer Ingelheim Pharma GmbH & Co.KG$63Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-11-24Alexion Pharmaceuticals, Inc.$4,996Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-11-20Smith+Nephew, Inc.$2,500GrantCash or cash equivalent2020
2020-11-20Smith+Nephew, Inc.$2,500GrantCash or cash equivalent2020
2020-11-20Smith+Nephew, Inc.$2,500GrantCash or cash equivalent2020
2020-11-20Smith+Nephew, Inc.$2,500GrantCash or cash equivalent2020
2020-11-19CSL Behring$2,965Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$1,428Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$1,342Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$1,045Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$963Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$632Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$408Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$365Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$261Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$62Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-19CSL Behring$18Research paymentIn-kind items and servicesHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2020
2020-11-18Medtronic USA, Inc.$7,376Space rental or facility fees (teaching hospital only)Cash or cash equivalentCD HORIZON Device, TL2020
2020-11-18Zimmer Biomet Holdings, Inc.$3,000GrantCash or cash equivalentGrants Device, General2020
2020-11-17AstraZeneca Pharmaceuticals LP$13,900Research paymentCash or cash equivalentFASENRA Drug, RespiratoryA Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Sa2020
2020-11-17Medical Device Business Services, Inc.$5,000GrantCash or cash equivalent2020
2020-11-17Medical Device Business Services, Inc.$3,000GrantCash or cash equivalent2020
2020-11-17Smith+Nephew, Inc.$606Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-11-17GE HEALTHCARE$357Charitable ContributionCash or cash equivalent2020
2020-11-16Medtronic USA, Inc.$5,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2020
2020-11-12Radius Health, Inc.$90,113Research paymentCash or cash equivalentPhase II Trial of Abaloparatide vs Placebo - Spinal Fusion - Phase II Trial of Abaloparatide vs Placebo in Post-Menopaus2020
2020-11-11Ortho Development Corporation$419Royalty or LicenseCash or cash equivalentSpinal Rod Device, ORTHOPEDIC DEVICE2020
2020-11-10Orion Corporation$2,778Research paymentCash or cash equivalentEffects of Oral Levosimendan on Respiratory Function in Patients With ALS: Open-Label Extension (REFALS-ES)2020
2020-11-09Takeda Pharmaceuticals U.S.A., Inc.$250Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2020
2020-11-06Smith+Nephew, Inc.$572Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-11-05Smith+Nephew, Inc.$5,650Research paymentCash or cash equivalentOR3O Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2020
2020-11-05Alexion Pharmaceuticals, Inc.$2,498Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-11-05Amgen Inc.$1,882Research paymentIn-kind items and servicesEnbrel Biological, InflammationEnbrel RA Remission Study2020
2020-11-04Stryker Corporation$7,747Research paymentCash or cash equivalentTRITANIUM Device, HIPSTRIDENT II TRITANIUM OUTCOMES STUDY2020
2020-11-04TREACE MEDICAL CONCEPTS, INC.$5,628Space rental or facility fees (teaching hospital only)Cash or cash equivalentLapiplasty System Device, Y2020
2020-11-04Stryker Corporation$1,793Research paymentCash or cash equivalentTRITANIUM Device, HIPSTRIDENT II TRITANIUM OUTCOMES STUDY2020
2020-11-04Stryker Corporation$1,597Research paymentCash or cash equivalentRESTORATION Device, HIPSRESTORATION; ANATOMIC DUAL MOBILITY (ADM) X3; ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE; I2020
2020-11-04Stryker Corporation$765Research paymentCash or cash equivalentSECUR-FIT Device, HIPSSECURFIT ADVANCED OUTCOMES STUDY2020
2020-11-04Stryker Corporation$162Research paymentCash or cash equivalentTRITANIUM Device, HIPSTRIDENT II TRITANIUM OUTCOMES STUDY2020
2020-11-03Alexion Pharmaceuticals, Inc.$10,000Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-11-03Alexion Pharmaceuticals, Inc.$2,900Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-11-03Alexion Pharmaceuticals, Inc.$1,000Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-11-03Takeda Pharmaceuticals U.S.A., Inc.$54Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2020
2020-11-01Boehringer Ingelheim Pharma GmbH & Co.KG$62Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-10-30EXACTECH, INC.$2,500GrantCash or cash equivalentNOVATION HIP Device, ORTHOPAEDIC2020
2020-10-28Smith+Nephew, Inc.$121,249Research paymentCash or cash equivalentSmith and Nephew Clinical Data Registry2020
2020-10-22Orthofix Medical, Inc.$11,650Research paymentCash or cash equivalentM6-C Artificial Cervical Disc Device, Prosthesis, Intervertebral DiscM6-C IDE2020
2020-10-22Zimmer Biomet Holdings, Inc.$5,000GrantCash or cash equivalentSpine-None Device, Spine2020
2020-10-20Smith+Nephew, Inc.$12,792Space rental or facility fees (teaching hospital only)Cash or cash equivalentVISIONAIRE Device, Recon Knees2020
2020-10-20Smith+Nephew, Inc.$9,921Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentVISIONAIRE Device, Recon Knees2020
2020-10-20CSL Behring$6,000Research paymentCash or cash equivalentPrivigen Biological, ImmunologyA Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro12020
2020-10-20CSL Behring$4,000Research paymentCash or cash equivalentPrivigen Biological, ImmunologyA Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro12020
2020-10-20CSL Behring$2,900Research paymentCash or cash equivalentPrivigen Biological, ImmunologyA Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro12020
2020-10-20CSL Behring$1,000Research paymentCash or cash equivalentPrivigen Biological, ImmunologyA Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro12020
2020-10-15Alexion Pharmaceuticals, Inc.$2,425Research paymentCash or cash equivalentSafety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis2020
2020-10-15Ortho Development Corporation$911Royalty or LicenseCash or cash equivalentSpinal Rod Device, ORTHOPEDIC DEVICE2020
2020-10-15Ortho Development Corporation$72Royalty or LicenseCash or cash equivalentISS Device, ORTHOPEDIC DEVICE2020
2020-10-09Smith+Nephew, Inc.$13,096Research paymentIn-kind items and servicesOXINIUM Hip Device, Recon Hips2020
2020-10-09Synthes GmbH$6,000GrantCash or cash equivalent2020
2020-10-08Zimmer Biomet Holdings, Inc.$5,000GrantCash or cash equivalentSpine-None Device, Spine2020
2020-10-07Stryker Corporation$10,016Research paymentCash or cash equivalentT2 Device, TRAUMA & EXTREMETIESMAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM2020
2020-10-07Stryker Corporation$1,500Research paymentCash or cash equivalentT2 Device, TRAUMA & EXTREMETIESMAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM2020
2020-10-07Stryker Corporation$1,500Research paymentCash or cash equivalentTRITANIUM Device, HIPSMAVRIC MAGNETIC RESONANCE IMAGING USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIATHLON CEMENTLES2020
2020-10-06Smith+Nephew, Inc.$23,550Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-10-06Abbott Laboratories$798Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-10-06Abbott Laboratories$111Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-10-05Synthes GmbH$32,500GrantCash or cash equivalent2020
2020-10-05Synthes GmbH$6,500GrantCash or cash equivalent2020
2020-10-05Smith+Nephew, Inc.$607Research paymentCash or cash equivalentBIRMINGHAM HIP Device, Recon HipsA Post-Approval Study of the Birmingham Hip Resurfacing (BHR) Radiological System Review2020
2020-10-05UOC USA INC$275Consulting FeeCash or cash equivalentU-Motion II, UTF Device, UOC Hip System2020
2020-10-01Limacorporate S.p.A.$100,000Consulting FeeCash or cash equivalentProduct Portfolio Device, Devices2020
2020-10-01GE HEALTHCARE$699EducationCash or cash equivalent2020
2020-10-01Boehringer Ingelheim Pharma GmbH & Co.KG$62Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-09-30EXACTECH, INC.$362,526Royalty or LicenseCash or cash equivalentOPTETRAK Device, ORTHOPAEDIC2020
2020-09-30EXACTECH, INC.$18,825Research paymentCash or cash equivalentOPTETRAK Device, ORTHOPAEDIC2020
2020-09-29UCB SA$12,400Research paymentCash or cash equivalentPhase 3, Multicenter, Randomized, Double-Blind, PBO-Controlled Study of Efficacy, Safety, and Tolerability of Zilucoplan2020
2020-09-19EXACTECH, INC.$5,188Space rental or facility fees (teaching hospital only)Cash or cash equivalentVANTAGE Device, ORTHOPAEDIC2020
2020-09-15Ortho Development Corporation$2,254Royalty or LicenseCash or cash equivalentSpinal Rod Device, ORTHOPEDIC DEVICE2020
2020-09-14Smith+Nephew, Inc.$5,265Research paymentCash or cash equivalentBIRMINGHAM HIP Device, Recon HipsA Post-Approval Study of the Birmingham Hip Resurfacing (BHR) Radiological System Review2020
2020-09-14Orthofix Medical, Inc.$1,434Research paymentCash or cash equivalentM6-C Artificial Cervical Disc Device, Prosthesis, Intervertebral DiscM6-C IDE2020
2020-09-11Amgen Inc.$3,738Research paymentIn-kind items and servicesPhase 2b SLE Dose-Finding2020
2020-09-10Medtronic USA, Inc.$10,763Space rental or facility fees (teaching hospital only)Cash or cash equivalentCD HORIZON Device, TL2020
2020-09-10Smith+Nephew, Inc.$750Research paymentCash or cash equivalentOR3O Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2020
2020-09-10Smith+Nephew, Inc.$750Research paymentCash or cash equivalentOR3O Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2020
2020-09-10Smith+Nephew, Inc.$750Research paymentCash or cash equivalentOR3O Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2020
2020-09-10Smith+Nephew, Inc.$750Research paymentCash or cash equivalentOR3O Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2020
2020-09-09Stryker Corporation$300Research paymentCash or cash equivalentRESTORATION Device, HIPSRESTORATION; ANATOMIC DUAL MOBILITY (ADM) X3; ACETABULAR SYSTEM STUDY WITH LONG TERM DATA COLLECTION FOR THE ACCOLADE; I2020
2020-09-09Orion Corporation$90Research paymentCash or cash equivalentEffects of Oral Levosimendan on Respiratory Function in Patients With ALS: Open-Label Extension (REFALS-ES)2020
2020-09-03Teva Pharmaceuticals USA, Inc.$5,643Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-09-03Novartis Pharmaceuticals Corporation$815Research paymentCash or cash equivalentVAY736 BiologicalA RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED MULTICENTER PHASE 2 DOSE RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF2020
2020-09-03Teva Pharmaceuticals USA, Inc.$450Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-09-03Teva Pharmaceuticals USA, Inc.$300Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-09-01Boehringer Ingelheim Pharma GmbH & Co.KG$60Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-08-31EXACTECH, INC.$233,684Royalty or LicenseCash or cash equivalentNOVATION HIP Device, ORTHOPAEDIC2020
2020-08-31EXACTECH, INC.$6,096Space rental or facility fees (teaching hospital only)Cash or cash equivalentVANTAGE Device, ORTHOPAEDIC2020
2020-08-26Teva Pharmaceuticals USA, Inc.$2,406Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-08-26Smith+Nephew, Inc.$877Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-08-26Boehringer Ingelheim Pharma GmbH & Co.KG$158Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-08-25Smith+Nephew, Inc.$270Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-08-20Smith+Nephew, Inc.$4,320Space rental or facility fees (teaching hospital only)Cash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$3,776Space rental or facility fees (teaching hospital only)Cash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$3,568Space rental or facility fees (teaching hospital only)Cash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$3,278Space rental or facility fees (teaching hospital only)Cash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$955Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$798Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$477Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Smith+Nephew, Inc.$320Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLENS Device, Sports Med Visualization2020
2020-08-20Teva Pharmaceuticals USA, Inc.$300Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-08-20Teva Pharmaceuticals USA, Inc.$200Research paymentCash or cash equivalentAJOVY Biological, Central Nervous SystemA Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including 2020
2020-08-19Abbott Laboratories$244Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-08-19Abbott Laboratories$229Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-08-18Smith+Nephew, Inc.$15,330Research paymentCash or cash equivalentOXINIUM Hip Device, Recon HipsA Multi-Center, Randomized Controlled Study of Efficacy and Safety of the OXINIUM DH Total Hip Replacement System in Sub2020
2020-08-17Boehringer Ingelheim Pharmaceuticals, Inc.$5Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2020
2020-08-15Medical Device Business Services, Inc.$1,836GrantCash or cash equivalent2020
2020-08-15Zimmer Biomet Holdings, Inc.$1,750GrantCash or cash equivalentGrants Device, General2020
2020-08-15Zimmer Biomet Holdings, Inc.$1,256GrantCash or cash equivalentGrants Device, General2020
2020-08-15Medical Device Business Services, Inc.$953GrantCash or cash equivalent2020
2020-08-15Medical Device Business Services, Inc.$896GrantCash or cash equivalent2020
2020-08-15Zimmer Biomet Holdings, Inc.$745GrantCash or cash equivalentGrants Device, General2020
2020-08-15Zimmer Biomet Holdings, Inc.$727GrantCash or cash equivalentGrants Device, General2020
2020-08-15Zimmer Biomet Holdings, Inc.$721GrantCash or cash equivalentGrants Device, General2020
2020-08-15Medical Device Business Services, Inc.$697GrantCash or cash equivalent2020
2020-08-15Medical Device Business Services, Inc.$685GrantCash or cash equivalent2020
2020-08-15Zimmer Biomet Holdings, Inc.$631GrantCash or cash equivalentGrants Device, General2020
2020-08-15Zimmer Biomet Holdings, Inc.$602GrantCash or cash equivalentGrants Device, General2020
2020-08-15Zimmer Biomet Holdings, Inc.$446GrantCash or cash equivalentGrants Device, General2020
2020-08-15Medical Device Business Services, Inc.$378GrantCash or cash equivalent2020
2020-08-15Medical Device Business Services, Inc.$372GrantCash or cash equivalent2020
2020-08-15Zimmer Biomet Holdings, Inc.$185GrantCash or cash equivalentGrants Device, General2020
2020-08-14Regeneron Pharmaceuticals, Inc.$22,217Research paymentCash or cash equivalentSTUDY TO EVALUATE ARTHROPLASTY SPECIMENS IN THE PHASE 3 FASINUMAB PROGRAM FOR OSTEOARTHRITIS OF THE KNEE AND HIP2020
2020-08-14Regeneron Pharmaceuticals, Inc.$1,462Research paymentCash or cash equivalentSTUDY TO EVALUATE ARTHROPLASTY SPECIMENS IN THE PHASE 3 FASINUMAB PROGRAM FOR OSTEOARTHRITIS OF THE KNEE AND HIP2020
2020-08-14Ortho Development Corporation$727Royalty or LicenseCash or cash equivalentSpinal Rod Device, ORTHOPEDIC DEVICE2020
2020-08-12Smith+Nephew, Inc.$121,249Research paymentCash or cash equivalentJOURNEY II BCS Device, Recon KneesSmith and Nephew Clinical Data Registry2020
2020-08-12GE HEALTHCARE$42,000Research paymentCash or cash equivalentSERIAL ULTRASONOGRAPHY FOR THE ASSESSMENT OF HEALING AND TIMING OF RETURN-TO-PLAY IN ATHLETES WITH LOWER EXTREMITY BONE 2020
2020-08-12Stryker Corporation$875Research paymentCash or cash equivalentREJUVENATE Device, HIPSCLINICAL AND RADIOGRAPHIC OUTCOME OF THE STRYKER REJUVENATE MODULAR STEMS2020
2020-08-11Orion Corporation$12,980Research paymentCash or cash equivalentEffects of Oral Levosimendan on Respiratory Function in Patients With ALS: Open-Label Extension (REFALS-ES)2020
2020-08-10Lima USA, Inc.$342,482Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2020
2020-08-07Stryker Corporation$5,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentNONE Device, NONE2020
2020-08-07Smith+Nephew, Inc.$4,528Space rental or facility fees (teaching hospital only)Cash or cash equivalentPERI-LOC PFP Device, Trauma Plates, Screws, and Nails2020
2020-08-07Smith+Nephew, Inc.$2,480Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentPERI-LOC PFP Device, Trauma Plates, Screws, and Nails2020
2020-08-07Smith+Nephew, Inc.$1,520Space rental or facility fees (teaching hospital only)Cash or cash equivalentPERI-LOC PFP Device, Trauma Plates, Screws, and Nails2020

The latest 200 records of 389.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Kings CountyNew York city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In New York, NY, county Kings County, NY, state New York; placed by its city name.

MeasurePlace (city or town)
New York, NY
County
Kings County, NY
State
New York
Population B010038,483,8442,631,58019,852,366
Population, 2020 census P18,804,1902,736,07420,201,249
Median age B0100238.236.539.8
Under 18 B0100120.2%22.2%20.5%
65 and over B0100116.6%15.5%17.9%
Households B110013,334,0881,009,9277,722,646
Foreign born B0500236.6%35.3%22.8%
Median household income B19013$80,483$80,263$85,974
Median family income B19113$91,707$88,947$106,873
Per capita income B19301$51,844$47,575$50,712
Poverty rate B1700117.9%19.1%14.0%
Unemployment rate B230258.0%7.9%6.4%
Civilian labor force B230254,392,2971,353,36110,171,766
Mean commute (minutes) B0801340.341.732.6
Bachelor's degree or higher B1500341.6%42.1%40.2%
Housing units B250013,678,4861,100,7728,585,241
Owner-occupied B2500332.8%29.5%54.3%
Renters B2500367.2%70.5%45.7%
Median home value B25077$777,600$905,000$423,800
Median gross rent B25064$1,821$1,833$1,621
White, not Hispanic B0300231.0%36.1%52.8%
Black B0300220.4%26.6%13.4%
Hispanic or Latino B0300228.5%19.0%19.8%
Asian B0300214.6%12.1%9.0%
American Indian and Alaska Native B030020.2%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York, NY.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.